The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency
Open accessAbstract
SUMMARY Mutations in BRCA1 or BRCA2 (BRCA) is synthetic lethal with poly(ADP-ribose) polymerase inhibitors (PARPi). Lethality is thought to derive from DNA double-stranded breaks (DSBs) necessitating BRCA function in homologous recombination (HR) and/or fork protection (FP). Here, we report instead that toxicity derives from replication gaps. BRCA1- or FANCJ-deficient cells, with common repair defects but distinct PARPi responses, reveal gaps as a distinguishing factor. We further uncouple HR, FP, and fork speed from PARPi response. Instead, gaps characterize BRCA-deficient cells, are diminished upon resistance, restored upon resensitization, and, when exposed, augment PARPi toxicity. Unchallenged BRCA1-deficient cells have elevated poly(ADP-ribose) and chromatin-associated PARP1, but aberrantly low XRCC1 consistent with defects in backup Okazaki fragment processing (OFP). 53BP1 loss resuscitates OFP by restoring XRCC1-LIG3 that suppresses the sensitivity of BRCA1-deficient cells to drugs targeting OFP or generating gaps. We highlight gaps as a determinant of PARPi toxicity changing the paradigm for synthetic lethal interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Murai, J., Huang, S.-Y. N., Das, B. B., Renaud, A., Zhang, Y., Doroshow, J. H., Ji, J., Takeda, S., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2753 · Cited by 2,192
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Ray Chaudhuri, A., & Nussenzweig, A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.53 · Cited by 1,786
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Bunting, S. F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.012 · Cited by 1,671
The DNA damage response and cancer therapy
Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,649
McCabe, N., Turner, N. C., Lord, C. J., Kluzek, K., Białkowska, A., Swift, S., Giavara, S., O'Connor, M. J., Tutt, A. N., Zdzienicka, M. Z., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0140 · Cited by 1,310
Schlacher, K., Christ, N., Siaud, N., Egashira, A., Wu, H., & Jasin, M. (2011) · Cell · doi:10.1016/j.cell.2011.03.041 · Cited by 1,255
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Sakai, W., Swisher, E. M., Karlan, B. Y., Agarwal, M. K., Higgins, J., Friedman, C., Villegas, E., Jacquemont, C., Farrugia, D. J., Couch, F. J., et al. (2008) · Nature · doi:10.1038/nature06633 · Cited by 1,086
Resistance to therapy caused by intragenic deletion in BRCA2
Edwards, S. L., Brough, R., Lord, C. J., Natrajan, R., Vatcheva, R., Levine, D. A., Boyd, J., Reis-Filho, J. S., & Ashworth, A. (2008) · Nature · doi:10.1038/nature06548 · Cited by 1,011
Bouwman, P., Aly, A., Escandell, J. M., Pieterse, M., Bartkova, J., van der Gulden, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1831 · Cited by 1,001
Self-citationSchlacher, K., Wu, H., & Jasin, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.015 · Cited by 936
Replication fork stability confers chemoresistance in BRCA-deficient cells
Ray Chaudhuri, A., Callen, E., Ding, X., Gogola, E., Duarte, A. A., Lee, J.-E., Wong, N., Lafarga, V., Calvo, J. A., Panzarino, N. J., et al. (2016) · Nature · doi:10.1038/nature18325 · Cited by 930
Self-citationATR prohibits replication catastrophe by preventing global exhaustion of RPA
Toledo, L. I., Altmeyer, M., Rask, M.-B., Lukas, C., Larsen, D. H., Povlsen, L. K., Bekker-Jensen, S., Mailand, N., Bartek, J., & Lukas, J. (2013) · Cell · doi:10.1016/j.cell.2013.10.043 · Cited by 911
Masson, M., Niedergang, C., Schreiber, V., Muller, S., Menissier-de Murcia, J., & de Murcia, G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3563 · Cited by 910
Fork Reversal and ssDNA Accumulation at Stalled Replication Forks Owing to Checkpoint Defects
Sogo, J. M., Lopes, M., & Foiani, M. (2002) · Science · doi:10.1126/science.1074023 · Cited by 823
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
Pommier, Y., O’Connor, M. J., & de Bono, J. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9246 · Cited by 739
Schreiber, V., Amé, J.-C., Dollé, P., Schultz, I., Rinaldi, B., Fraulob, V., Ménissier-de Murcia, J., & de Murcia, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202390200 · Cited by 705
Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells
Zellweger, R., Dalcher, D., Mutreja, K., Berti, M., Schmid, J. A., Herrador, R., Vindigni, A., & Lopes, M. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201406099 · Cited by 677
Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00304-x · Cited by 674
Self-citationLukas, C., Savic, V., Bekker-Jensen, S., Doil, C., Neumann, B., Sølvhøj Pedersen, R., Grøfte, M., Chan, K. L., Hickson, I. D., Bartek, J., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2201 · Cited by 667
El-Khamisy, S. F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg761 · Cited by 659
The shieldin complex mediates 53BP1-dependent DNA repair
Noordermeer, S. M., Adam, S., Setiaputra, D., Barazas, M., Pettitt, S. J., Ling, A. K., Olivieri, M., Álvarez-Quilón, A., Moatti, N., Zimmermann, M., et al. (2018) · Nature · doi:10.1038/s41586-018-0340-7 · Cited by 645
Self-citationCaldecott, K. W., Aoufouchi, S., Johnson, P., & Shall, S. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.22.4387 · Cited by 620
Norquist, B., Wurz, K. A., Pennil, C. C., Garcia, R., Gross, J., Sakai, W., Karlan, B. Y., Taniguchi, T., & Swisher, E. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.2980 · Cited by 577
Lopes, M., Foiani, M., & Sogo, J. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2005.11.015 · Cited by 563
Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis
Hashimoto, Y., Ray Chaudhuri, A., Lopes, M., & Costanzo, V. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1927 · Cited by 548
High speed of fork progression induces DNA replication stress and genomic instability
Maya-Mendoza, A., Moudry, P., Merchut-Maya, J. M., Lee, M., Strauss, R., & Bartek, J. (2018) · Nature · doi:10.1038/s41586-018-0261-5 · Cited by 514
Topoisomerase I poisoning results in PARP-mediated replication fork reversal
Ray Chaudhuri, A., Hashimoto, Y., Herrador, R., Neelsen, K. J., Fachinetti, D., Bermejo, R., Cocito, A., Costanzo, V., & Lopes, M. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2258 · Cited by 499
Mechanisms of PARP inhibitor sensitivity and resistance
D’Andrea, A. D. (2018) · DNA Repair · doi:10.1016/j.dnarep.2018.08.021 · Cited by 489
Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
Lord, C. J., Tutt, A. N. J., & Ashworth, A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-050913-022545 · Cited by 471
Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition
Berti, M., Ray Chaudhuri, A., Thangavel, S., Gomathinayagam, S., Kenig, S., Vujanovic, M., Odreman, F., Glatter, T., Graziano, S., Mendoza-Maldonado, R., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2501 · Cited by 452
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
Levitus, M., Waisfisz, Q., Godthelp, B. C., Vries, Y. D., Hussain, S., Wiegant, W. W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M. A., Pals, G., et al. (2005) · Nature Genetics · doi:10.1038/ng1625 · Cited by 432
53BP1–RIF1–shieldin counteracts DSB resection through CST- and Polα-dependent fill-in
Mirman, Z., Lottersberger, F., Takai, H., Kibe, T., Gong, Y., Takai, K., Bianchi, A., Zimmermann, M., Durocher, D., & de Lange, T. (2018) · Nature · doi:10.1038/s41586-018-0324-7 · Cited by 427
Synthetic lethal therapies for cancer: what’s next after PARP inhibitors?
Ashworth, A., & Lord, C. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0055-6 · Cited by 420
ATR phosphorylates SMARCAL1 to prevent replication fork collapse
Couch, F. B., Bansbach, C. E., Driscoll, R., Luzwick, J. W., Glick, G. G., Bétous, R., Carroll, C. M., Jung, S. Y., Qin, J., Cimprich, K. A., et al. (2013) · Genes & Development · doi:10.1101/gad.214080.113 · Cited by 406
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
Zimmermann, M., Murina, O., Reijns, M. A. M., Agathanggelou, A., Challis, R., Tarnauskaitė, Ž., Muir, M., Fluteau, A., Aregger, M., McEwan, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0291-z · Cited by 401
Litman, R., Peng, M., Jin, Z., Zhang, F., Zhang, J., Powell, S., Andreassen, P. R., & Cantor, S. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.004 · Cited by 396
Self-citationYazinski, S. A., Comaills, V., Buisson, R., Genois, M.-M., Nguyen, H. D., Ho, C. K., Todorova Kwan, T., Morris, R., Lauffer, S., Nussenzweig, A., et al. (2017) · Genes & Development · doi:10.1101/gad.290957.116 · Cited by 395
Hanzlikova, H., Kalasova, I., Demin, A. A., Pennicott, L. E., Cihlarova, Z., & Caldecott, K. W. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.004 · Cited by 393
Gogola, E., Duarte, A. A., de Ruiter, J. R., Wiegant, W. W., Schmid, J. A., de Bruijn, R., James, D. I., Guerrero Llobet, S., Vis, D. J., Annunziato, S., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.008 · Cited by 374
Self-citationKolinjivadi, A. M., Sannino, V., De Antoni, A., Zadorozhny, K., Kilkenny, M., Técher, H., Baldi, G., Shen, R., Ciccia, A., Pellegrini, L., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.001 · Cited by 372
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia
Levran, O., Attwooll, C., Henry, R. T., Milton, K. L., Neveling, K., Rio, P., Batish, S. D., Kalb, R., Velleuer, E., Barral, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1624 · Cited by 370
Lundin, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki681 · Cited by 367
Replication fork reversal triggers fork degradation in BRCA2-defective cells
Mijic, S., Zellweger, R., Chappidi, N., Berti, M., Jacobs, K., Mutreja, K., Ursich, S., Ray Chaudhuri, A., Nussenzweig, A., Janscak, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01164-5 · Cited by 360
The Role of DNA Single- and Double-Strand Breaks in Cell Killing by Ionizing Radiation
Olive, P. L. (1998) · Radiation Research · doi:10.2307/3579807 · Cited by 345
PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers
Pilié, P. G., Gay, C. M., Byers, L. A., O'Connor, M. J., & Yap, T. A. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0968 · Cited by 330
Sakai, W., Swisher, E. M., Jacquemont, C., Chandramohan, K. V., Couch, F. J., Langdon, S. P., Wurz, K., Higgins, J., Villegas, E., & Taniguchi, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1178 · Cited by 321
Chen, J., Jin, K., Chen, M., Pei, W., Kawaguchi, K., Greenberg, D. A., & Simon, R. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010232.x · Cited by 312
Cao, L., Xu, X., Bunting, S. F., Liu, J., Wang, R.-H., Cao, L. L., Wu, J. J., Peng, T.-N., Chen, J., Nussenzweig, A., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.037 · Cited by 309
Galanos, P., Vougas, K., Walter, D., Polyzos, A., Maya-Mendoza, A., Haagensen, E. J., Kokkalis, A., Roumelioti, F.-M., Gagos, S., Tzetis, M., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3378 · Cited by 308
Strom, C. E., Johansson, F., Uhlen, M., Szigyarto, C. A.-K., Erixon, K., & Helleday, T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1241 · Cited by 296
Mladenov, E., Magin, S., Soni, A., & Iliakis, G. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00113 · Cited by 290
Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype
Sawyer, S. L., Tian, L., Kähkönen, M., Schwartzentruber, J., Kircher, M., University of Washington Centre for Mendelian Genomics, FORGE Canada Consortium, Majewski, J., Dyment, D. A., Innes, A. M., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1156 · Cited by 283
Wang, A. T., Kim, T., Wagner, J. E., Conti, B. A., Lach, F. P., Huang, A. L., Molina, H., Sanborn, E. M., Zierhut, H., Cornes, B. K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.009 · Cited by 273
PRIMPOL-Mediated Adaptive Response Suppresses Replication Fork Reversal in BRCA-Deficient Cells
Quinet, A., Tirman, S., Jackson, J., Šviković, S., Lemaçon, D., Carvajal-Maldonado, D., González-Acosta, D., Vessoni, A. T., Cybulla, E., Wood, M., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.10.008 · Cited by 263
Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein
Lomonosov, M., Anand, S., Sangrithi, M., Davies, R., & Venkitaraman, A. R. (2003) · Genes & Development · doi:10.1101/gad.279003 · Cited by 256
Monoclonal Antibody to Single-Stranded DNA Is a Specific and Sensitive Cellular Marker of Apoptosis
Frankfurt, O. S., Robb, J. A., Sugarbaker, E. V., & Villa, L. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0240 · Cited by 244
Cantor, S., Drapkin, R., Zhang, F., Lin, Y., Han, J., Pamidi, S., & Livingston, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308717101 · Cited by 240
Self-citationDNA Fiber Analysis: Mind the Gap!
Quinet, A., Carvajal-Maldonado, D., Lemacon, D., & Vindigni, A. (2017) · Methods in Enzymology · doi:10.1016/bs.mie.2017.03.019 · Cited by 240
Lossaint, G., Larroque, M., Ribeyre, C., Bec, N., Larroque, C., Décaillet, C., Gari, K., & Constantinou, A. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.023 · Cited by 232
Leppard, J. B., Dong, Z., Mackey, Z. B., & Tomkinson, A. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5919-5927.2003 · Cited by 230
Poly(ADP-Ribose) Polymerase Is Hyperactivated in Homologous Recombination–Defective Cells
Gottipati, P., Vischioni, B., Schultz, N., Solomons, J., Bryant, H. E., Djureinovic, T., Issaeva, N., Sleeth, K., Sharma, R. A., & Helleday, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4716 · Cited by 227
Replication Gaps Underlie BRCA Deficiency and Therapy Response
Panzarino, N. J., Krais, J. J., Cong, K., Peng, M., Mosqueda, M., Nayak, S. U., Bond, S. M., Calvo, J. A., Doshi, M. B., Bere, M., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1602 · Cited by 212
Self-citationDNA strand breaks and apoptosis induced by oxaliplatin in cancer cells
Faivre, S., Chan, D., Salinas, R., Woynarowska, B., & Woynarowski, J. M. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00260-0 · Cited by 211
PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA
Sugimura, K., Takebayashi, S.-I., Taguchi, H., Takeda, S., & Okumura, K. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806068 · Cited by 211
H4K20me0 marks post-replicative chromatin and recruits the TONSL–MMS22L DNA repair complex
Saredi, G., Huang, H., Hammond, C. M., Alabert, C., Bekker-Jensen, S., Forne, I., Reverón-Gómez, N., Foster, B. M., Mlejnkova, L., Bartke, T., et al. (2016) · Nature · doi:10.1038/nature18312 · Cited by 211
Muvarak, N. E., Chowdhury, K., Xia, L., Robert, C., Choi, E. Y., Cai, Y., Bellani, M., Zou, Y., Singh, Z. N., Duong, V. H., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.002 · Cited by 201
Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets
Mengwasser, K. E., Adeyemi, R. O., Leng, Y., Choi, M. Y., Clairmont, C., D’Andrea, A. D., & Elledge, S. J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.12.008 · Cited by 197
The DNA Translocase FANCM/MHF Promotes Replication Traverse of DNA Interstrand Crosslinks
Huang, J., Liu, S., Bellani, M. A., Thazhathveetil, A. K., Ling, C., de Winter, J. P., Wang, Y., Wang, W., & Seidman, M. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.021 · Cited by 192
Hanzlikova, H., Gittens, W., Krejcikova, K., Zeng, Z., & Caldecott, K. W. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1246 · Cited by 192
Regulation of Poly(ADP-ribose) Polymerase-1 by DNA Structure-specific Binding
Lonskaya, I., Potaman, V. N., Shlyakhtenko, L. S., Oussatcheva, E. A., Lyubchenko, Y. L., & Soldatenkov, V. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413483200 · Cited by 186
Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4Preprint
Guillemette, S., Serra, R. W., Peng, M., Hayes, J. A., Konstantinopoulos, P. A., Green, M. R., & Cantor, S. B. (2015) · Genes & Development · doi:10.1101/gad.256214.114 · Cited by 174
Self-citationKolinjivadi, A. M., Sannino, V., Antoni, A. D., Técher, H., Baldi, G., & Costanzo, V. (2017) · FEBS Letters · doi:10.1002/1873-3468.12556 · Cited by 168
Defining and Modulating ‘BRCAness’
Byrum, A. K., Vindigni, A., & Mosammaparast, N. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.06.005 · Cited by 167
XRCC3 and Rad51 Modulate Replication Fork Progression on Damaged Vertebrate Chromosomes
Henry-Mowatt, J., Jackson, D., Masson, J.-Y., Johnson, P. A., Clements, P. M., Benson, F. E., Thompson, L. H., Takeda, S., West, S. C., & Caldecott, K. W. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00132-1 · Cited by 164
Pillay, N., Tighe, A., Nelson, L., Littler, S., Coulson‐Gilmer, C., Bah, N. K., Golder, A., Bakker, B., Spierings, D. C. J., James, D. I., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.004 · Cited by 161
Feng, W., & Jasin, M. (2017) · Nature Communications · doi:10.1038/s41467-017-00634-0 · Cited by 158
Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD
Hewitt, G., Borel, V., Segura‐Bayona, S., Takaki, T., Ruis, P., Bellelli, R., Lehmann, L. C., Sommerová, L., Vančevska, A., Tomás‐Loba, A., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.12.006 · Cited by 158
Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA -deficient cells to PARP inhibitors
Fugger, K., Bajrami, I., dos Santos, M. S., Young, S. J., Kunzelmann, S., Kelly, G. P., Hewitt, G., Patel, H., Goldstone, R. J., Carell, T., et al. (2021) · Science · doi:10.1126/science.abb4542 · Cited by 153
Verma, P., Zhou, Y., Cao, Z., Deraska, P. V., Deb, M., Arai, E., Li, W., Shao, Y., Puentes, L. N., Li, Y. H., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-020-00624-3 · Cited by 152
Mutreja, K., Krietsch, J., Hess, J., Ursich, S., Berti, M., Roessler, F. K., Zellweger, R., Patra, M., Gasser, G., & Lopes, M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.019 · Cited by 150
Thakar, T., Leung, W., Nicolae, C. M., Clements, K. E., Shen, B., Bielinsky, A., & Moldovan, G. (2020) · Nature Communications · doi:10.1038/s41467-020-16096-w · Cited by 143
Replication-Coupled Dilution of H4K20me2 Guides 53BP1 to Pre-replicative Chromatin
Pellegrino, S., Michelena, J., Teloni, F., Imhof, R., & Altmeyer, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.016 · Cited by 141
Burhans, W. C., Vassilev, L. T., Wu, J., Sogo, J. M., Nallaseth, F. S., & DePamphilis, M. L. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb05013.x · Cited by 140
p53 and p21 Regulate Error-Prone DNA Repair to Yield a Lower Mutation Load
Avkin, S., Sevilya, Z., Toube, L., Geacintov, N. E., Chaney, S. G., Oren, M., & Livneh, Z. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.022 · Cited by 140
Radiation-induced mitotic catastrophe in PARG-deficient cells
Amé, J., Fouquerel, E., Gauthier, L., Biard, D. S. F., Boussin, F. D., Dantzer, F., de MURCIA, G., & Schreiber, V. (2009) · Journal of Cell Science · doi:10.1242/jcs.039115 · Cited by 139
Latest clinical evidence and further development of PARP inhibitors in ovarian cancer
Mirza, M. R., Pignata, S., & Ledermann, J. A. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy174 · Cited by 134
Michelena, J., Lezaja, A., Teloni, F., Schmid, T., Imhof, R., & Altmeyer, M. (2018) · Nature Communications · doi:10.1038/s41467-018-05031-9 · Cited by 131
Smith, M. A., Reynolds, C. P., Kang, M. H., Kolb, E. A., Gorlick, R. G., Carol, H., Lock, R. B., Keir, S. T., Maris, J. M., Billups, C. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2572 · Cited by 122
Nuclear PARPs and genome integrityPreprint
Azarm, K., & Smith, S. H. (2020) · Genes & Development · doi:10.1101/gad.334730.119 · Cited by 122
Álvarez-Quilón, A., Wojtaszek, J. L., Mathieu, M., Patel, T., Appel, C. D., Hustedt, N., Rossi, S. E., Wallace, B. D., Setiaputra, D., Adam, S., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.021 · Cited by 122
Adam, S., Rossi, S. E., Moatti, N., De Marco Zompit, M., Xue, Y., Ng, T. F., Álvarez-Quilón, A., Desjardins, J., Bhaskaran, V., Martino, G., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00266-w · Cited by 121
Nayak, S. U., Calvo, J. A., Cong, K., Peng, M., Berthiaume, E. A., Jackson, J., Zaino, A. M., Vindigni, A., Hadden, M. K., & Cantor, S. B. (2020) · Science Advances · doi:10.1126/sciadv.aaz7808 · Cited by 120
Self-citationUbiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability
Lachaud, C., Moreno, A., Marchesi, F., Toth, R. L., Blow, J. J., & Rouse, J. W. (2016) · Science · doi:10.1126/science.aad5634 · Cited by 119
Minding the gap: The underground functions of BRCA1 and BRCA2 at stalled replication forks
Nagaraju, G., & Scully, R. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.020 · Cited by 117
Schoonen, P. M., Talens, F., Stok, C., Gogola, E., Heijink, A. M., Bouwman, P., Foijer, F., Tarsounas, M., Blatter, S., Jonkers, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15981 · Cited by 108
Self-citationSchmid, J. A., Berti, M., Walser, F., Raso, M. C., Schmid, F. M., Krietsch, J., Stoy, H., Zwicky, K., Ursich, S., Freire, R., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.011 · Cited by 108
Dias, M. P., Tripathi, V., van der Heijden, I., Cong, K., Manolika, E. M., Bhin, J., Gogola, E., Galanos, P., Annunziato, S., Lieftink, C., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.005 · Cited by 108
Self-citationLai, X., Broderick, R., Bergoglio, V., Zimmer, J., Badie, S., Niedźwiedź, W., Hoffmann, J., & Tarsounas, M. (2017) · Nature Communications · doi:10.1038/ncomms15983 · Cited by 107
Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
Ledermann, J. A., & Pujade-Lauraine, É. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919849753 · Cited by 107
Vallerga, M. B., Mansilla, S. F., Federico, M. B., Bertolin, A. P., & Gottifredi, V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508543112 · Cited by 104
RADX Modulates RAD51 Activity to Control Replication Fork Protection
Bhat, K. P., Krishnamoorthy, A., Dungrawala, H., Garcin, E. B., Modesti, M., & Cortez, D. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.061 · Cited by 104
FANCM regulates DNA chain elongation and is stabilized by S‐phase checkpoint signalling
Luke-Glaser, S., Luke, B., Grossi, S., & Constantinou, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.371 · Cited by 102
FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination
Guo, E., Ishii, Y., Mueller, J., Srivatsan, A., Gahman, T. C., Putnam, C. D., Wang, J. Y. J., & Kolodner, R. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009237117 · Cited by 100
BACH1 is a DNA repair protein supporting BRCA1 damage response
Peng, M., Litman, R., Jin, Z., Fong, G., & Cantor, S. B. (2006) · Oncogene · doi:10.1038/sj.onc.1209257 · Cited by 88
Self-citationBase Excision Repair Defects Invoke Hypersensitivity to PARP Inhibition
Horton, J. K., Stefanick, D. F., Prasad, R., Gassman, N. R., Kedar, P. S., & Wilson, S. H. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0502 · Cited by 83
Translesion synthesis mechanisms depend on the nature of DNA damage in UV-irradiated human cells
Quinet, A., Martins, D. J., Vessoni, A. T., Biard, D., Sarasin, A., Stary, A., & Menck, C. F. M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw280 · Cited by 76
Wong, R. P. C., García‐Rodríguez, N., Zilio, N., Hanulová, M., & Ulrich, H. D. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.015 · Cited by 75
Opposing Roles of FANCJ and HLTF Protect Forks and Restrain Replication during Stress
Peng, M., Cong, K., Panzarino, N. J., Nayak, S. U., Calvo, J. A., Deng, B., Zhu, L. J., Mórocz, M., Hegedűs, L., Haracska, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.065 · Cited by 71
Self-citationPerspectives on PARPs in S Phase
Hanzlíková, H., & Caldecott, K. W. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.03.008 · Cited by 68
Kumamoto, S., Nishiyama, A., Chiba, Y., Miyashita, R., Konishi, C., Azuma, Y., & Nakanishi, M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab269 · Cited by 67
Zadorozhny, K., Sannino, V., Beláň, O., Mlčoušková, J., Špı́rek, M., Costanzo, V., & Krejčí, L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.062 · Cited by 64
Homology-directed repair protects the replicating genome from metabolic assaults
Somyajit, K., Spies, J., Coscia, F., Kirik, U., Rask, M., Lee, J., Neelsen, K. J., Mund, A., Jensen, L. J., Paull, T. T., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.01.011 · Cited by 63
Nur‐E‐Kamal, A., Li, T., Zhang, A., Qi, H., Hars, E. S., & Liu, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212915200 · Cited by 60
Relation between the human fibroblast strain 46BR and cell lines representative of Bloom's syndrome.
Lehmann, A. R., Willis, A. E., Broughton, B. C., James, M. R., Steingrimsdottir, H., Harcourt, S. A., Arlett, C. F., & Lindahl, T. L. (1988) · PubMed · Cited by 60
Fanconi Anemia Group J Helicase and MRE11 Nuclease Interact To Facilitate the DNA Damage Response
Suhasini, A. N., Sommers, J. A., Muniandy, P. A., Coulombe, Y., Cantor, S. B., Masson, J., Seidman, M. M., & Brosh, R. M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01256-12 · Cited by 59
Self-citationSu, X., Bernal, J. A., & Venkitaraman, A. R. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1490 · Cited by 52
Saxena, S., Dixit, S., Somyajit, K., & Nagaraju, G. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.008 · Cited by 52
Ward, T. A., McHugh, P. J., & Durant, S. T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179278 · Cited by 45
Brca1-Deficient Murine Mammary Epithelial Cells have Increased Sensitivity to CDDP and MMS
Sgagias, M. K., Wagner, K., Hamik, B., Stoeger, S. M., Spieker, R. S., Huber, L. J., Chodosh, L. A., & Cowan, K. H. (2004) · Cell Cycle · doi:10.4161/cc.3.11.1211 · Cited by 44
Cancer-associated mutations in the iron-sulfur domain of FANCJ affect G-quadruplex metabolism
Odermatt, D. C., Lee, W. T. C., Wild, S., Jóźwiakowski, S. K., Rothenberg, E., & Gari, K. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008740 · Cited by 37
Self-citationAlternative Okazaki Fragment Ligation Pathway by DNA Ligase III
Arakawa, H., & Iliakis, G. E. (2015) · Genes · doi:10.3390/genes6020385 · Cited by 35
Structure-Guided Optimization of Replication Protein A (RPA)–DNA Interaction Inhibitors
Gavande, N. S., VanderVere-Carozza, P. S., Pawelczak, K. S., Vernon, T. L., Jordan, M. R., & Turchi, J. J. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00440 · Cited by 30
Self-citationSriramkumar, S., Matthews, T. D., Ghobashi, A. H., Miller, S. A., VanderVere-Carozza, P. S., Pawelczak, K. S., Nephew, K. P., Turchi, J. J., & O’Hagan, H. M. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0396 · Cited by 27
Self-citationLee, W. C., Yin, Y.-D., Morten, M. J., Tonzi, P., Gwo, P. P., Odermatt, D. C., Modesti, M., Cantor, S. B., Gari, K., Huang, T. T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22830-9 · Cited by 25
Self-citationReplicated chromatin curtails 53BP1 recruitment in BRCA1-proficient and BRCA1-deficient cells
Michelena, J., Pellegrino, S., Spegg, V., & Altmeyer, M. (2021) · Life Science Alliance · doi:10.26508/lsa.202101023 · Cited by 23
Fork Protection and Therapy Resistance in Hereditary Breast Cancer
Cantor, S. B., & Calvo, J. A. (2017) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2017.82.034413 · Cited by 22
Self-citationMechanism for Synthetic Lethality in BRCA-Deficient Cancers: No Longer Lagging Behind
van Wietmarschen, N., & Nussenzweig, A. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.045 · Cited by 22
Probing the Spatial Organization of Molecular Complexes Using Triple-Pair-Correlation
Yin, Y., & Rothenberg, E. (2016) · Scientific Reports · doi:10.1038/srep30819 · Cited by 21
Self-citationXu, X., Chen, E. S., Mo, L., Zhang, L., Shao, F., Miao, K., Liu, J., Su, S. M., Valecha, M. V., Chan, U. I., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy398 · Cited by 21
Nath, S., Somyajit, K., Mishra, A., Scully, R., & Nagaraju, G. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx586 · Cited by 19
CIP2A is a prime synthetic-lethal target for BRCA-mutated cancersPreprint
Adam, S., Rossi, S. E., Moatti, N., Zompit, M. D. M., Ng, T. F., Álvarez-Quilón, A., Desjardins, J., Bhaskaran, V., Martino, G., Setiaputra, D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.08.430060 · Cited by 17
Superfast DNA replication causes damage in cancer cells
Quinet, A., & Vindigni, A. (2018) · Nature · doi:10.1038/d41586-018-05501-6 · Cited by 16
Miller, R. E., Crusz, S. M., & Ledermann, J. A. (2019) · Future Oncology · doi:10.2217/fon-2019-0057 · Cited by 14
Dias, M. P., Tripathi, V., van der Heijden, I., Cong, K., Manolika, E.-M., Bhin, J., Gogola, E., Galanos, P., Annunziato, S., Lieftink, C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.24.436323 · Cited by 10
Self-citation
Cited by
Targeting DNA damage response pathways in cancer
Groelly, F. J., Fawkes, M., Dagg, R. A., Blackford, A. N., & Tarsounas, M. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00535-5 · Cited by 836
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Rose, M., Burgess, J. T., O’Byrne, K., Richard, D. J., & Bolderson, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564601 · Cited by 719
Clinical and translational advances in ovarian cancer therapy
Konstantinopoulos, P. A., & Matulonis, U. A. (2023) · Nature Cancer · doi:10.1038/s43018-023-00617-9 · Cited by 394
Metadata
- Authors
- Cong, K., Peng, M., Kousholt, A. N., Lee, W. T. C., Lee, S., Nayak, S., Krais, J., VanderVere-Carozza, P. S., Pawelczak, K. S., Calvo, J., Panzarino, N. J., Turchi, J. J., Johnson, N., Jonkers, J., Rothenberg, E., & Cantor, S. B.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 81
- Issue
- 15
- Pages
- 3128-3144.e7
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W3176275742
- Cited by
- 345
- References
- 137
- FWCI
- 19.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.